Advisor Group Holdings, Inc. Qiagen N.V. Transaction History

Advisor Group Holdings, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$35.55 - $43.57 $137,614 - $168,659	-3,871 Reduced 41.88%	5,373 $233,000
Q3 2023 Nov 13, 2023	BUY	$39.13 - $47.24 $149,633 - $180,645	3,824 Added 70.55%	9,244 $374,000
Q2 2023 Aug 21, 2023	SELL	$43.93 - $46.76 $13,530 - $14,402	-308 Reduced 5.38%	5,420 $244,000
Q2 2023 Aug 10, 2023	BUY	$43.93 - $46.76 $45,731 - $48,677	1,041 Added 22.21%	5,728 $257,000
Q1 2023 May 12, 2023	SELL	$45.29 - $50.76 $30,072 - $33,704	-664 Reduced 12.41%	4,687 $215,000
Q4 2022 Feb 10, 2023	SELL	$41.91 - $50.48 $23,721 - $28,571	-566 Reduced 9.57%	5,351 $266,000
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $10,838 - $13,361	-265 Reduced 4.29%	5,917 $244,000
Q2 2022 Aug 10, 2022	BUY	$42.98 - $49.77 $38,037 - $44,046	885 Added 16.71%	6,182 $292,000
Q1 2022 May 04, 2022	BUY	$42.23 - $54.3 $16,216 - $20,851	384 Added 7.82%	5,297 $307,000
Q3 2021 Nov 05, 2021	SELL	$46.55 - $56.83 $33,190 - $40,519	-713 Reduced 12.67%	4,913 $253,000
Q2 2021 Aug 02, 2021	SELL	$46.28 - $52.75 $592,384 - $675,200	-12,800 Reduced 69.47%	5,626 $272,000
Q1 2021 May 13, 2021	BUY	$46.25 - $56.02 $370,832 - $449,168	8,018 Added 77.04%	18,426 $897,000
Q4 2020 Feb 10, 2021	BUY	$46.09 - $54.74 $225,841 - $268,226	4,900 Added 88.96%	10,408 $549,000
Q3 2020 Nov 12, 2020	SELL	$42.51 - $52.42 $119,750 - $147,667	-2,817 Reduced 33.84%	5,508 $282,000
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $49,125 - $55,183	-1,244 Reduced 13.0%	8,325 $354,000
Q1 2020 May 18, 2020	BUY	$33.17 - $41.6 $317,403 - $398,070	9,569 New	9,569 $399,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.92B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.